Editorials

Genetic engineering in athletes

BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a607 (Published 07 July 2008) Cite this as: BMJ 2008;337:a607
  1. Dominic Wells, professor
  1. 1Department of Cellular and Molecular Neuroscience, Imperial College, London W12 0NN
  1. d.wells{at}imperial.ac.uk

    Safeguards are needed before the hypothetical threat becomes a reality

    Athletes who want to maximise their performance are continually tempted to use illegal drugs to gain competitive advantage and to aid recovery from training and injuries. Recent revelations of widespread doping arising from investigations of the distributionof the anabolic steroid tetrahydrogestrinone by the American company BALCO (Bay Area Laboratory Co-operative) demonstrate the extent of this problem in world class athletes.1

    Some commentators have raised concerns that genetic modification or “gene doping” will be the next step in the search for enhanced performance.2 3 4 5 These concerns are based on some impressive studies in genetically modified rodents where manipulation of individual genes has increased muscle mass, muscle strength, or running endurance, depending on the gene that was manipulated. Reviews of these animal studies conclude that such genetic manipulations could also improve human athletic performance.6 7

    How likely is it that athletes will use genetic modification? About 10% of athletes have used existing drugs,8 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe